BUY Zydus Lifesciences — Rakesh Bansal, 22 Sept 2026

byRakesh BansalHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via CNBC Awaaz.

Entry₹1,170.9Inferred

Target₹1,200

Stop loss₹1,150-1.78% risk

CMP₹1,162.35h ago

Active-0.73%+3.24%upside left 14d left

Follow Rakesh Bansal for new calls(32% target hit, 87 closed calls)Get alerts Watch ZYDUSLIFE for new buy/sell callsGet alerts See 181 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 9:26 pm IST

3 supporting1 opposing

Supports the BUY call (3)

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 4d ago

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth

NewsNdtv-Profit·9 Sept · 2w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·22 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Zydus Lifesciences Limited — Rakesh Bansal

AI Assessment